Allspring Global Investments Holdings, LLC Bluebird Bio, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 2,868 shares of BLUE stock, worth $23,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,868Holding current value
$23,947% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding BLUE
# of Institutions
146Shares Held
63.3MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$129 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$87.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$39.1 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$39 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$32.1 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $644M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...